Trevor James
Vaccines have been one of the most significant inventions in the history of medicine, having profoundly improved public health by preventing infectious diseases. They work by teaching the immune system to create antibodies to help fight off a particular pathogen. The immune system can be divided into two subsystems: the innate or general resistance system, and the adaptive system. Both subsystems interact with each other to provide an effective immune response. The adaptive immune system is composed of B-cells/antibodies and T-cells, which are activated by vaccines to produce memory cells that enable long-lived protection against the target pathogen. This memory allows the adaptive immune system to respond more rapidly to the pathogen with each successive exposure.
| Characteristics | Values |
|---|---|
| Definition of adaptive immune response | The adaptive immune system has memory, which means that it will respond more rapidly to a particular pathogen with each successive exposure. |
| Types of adaptive immune response | Humoral immunity (B-cells/antibodies) and cell-mediated immunity (T-cells) |
| Function of adaptive immune response | Humoral immunity functions against extracellular pathogenic agents and toxins. Cell-mediated immunity functions primarily against intracellular pathogens. |
| Role of vaccines | Vaccines induce antigen-specific memory in adaptive immune cells that enable long-lived protection against the target pathogen. |
| Types of vaccines | Replicating live attenuated vaccines and non-replicating vaccines |
| Examples of successful vaccines | Smallpox, meningitis, tetanus, measles, wild poliovirus, COVID-19 |
Explore related products
What You'll Learn
Vaccines induce memory in adaptive immune cells
Vaccines teach the immune system to create antibodies to help fight off a particular pathogen. The immune system can be divided into two subsystems: the innate immune system and the adaptive immune system. The adaptive immune system has memory, which means that it will respond more rapidly to a particular pathogen with each successive exposure. This is called immunological memory.
Memory responses are called secondary, tertiary, and so on, depending on the number of exposures to the antigen. The characteristics of antibodies produced in secondary and subsequent responses are distinct from those produced in the primary response to the same antigen. This is particularly clear in the case of the antibody response, where antibodies produced in response to the pathogen's antigen are an important part of the immune system.
Memory B-cells and T-cells are produced by both vaccination and natural infection. These memory cells can protect a person for life, while others are shorter-lived. The durability of immune memory after vaccination remains unclear, but antibodies declined from peak levels but remained detectable in most subjects at 6 months.
Kids' Mandatory Vaccines: Insurance Coverage Explained
You may want to see also
Explore related products
Vaccines alter adaptive immune cell populations
The immune system can be divided into two main subsystems: the innate/general resistance system and the adaptive system. The adaptive immune system has two arms: humoral immunity, which is composed of B-cells and antibodies, and cell-mediated immunity, which is composed of T-cells.
Vaccines induce long-term stimulation of both the humoral and cell-mediated arms of the adaptive system by producing effector cells and memory cells. The B-cells produce antibodies that fight off infection, and the T-cells recognise and kill infected cells, stopping the infection from spreading.
Vaccines such as BCG, DTP, and MCV have been associated with changes in all-cause infant mortality. Studies have reported changes in the numbers or proportions of adaptive immune cell populations, as well as evidence of effects on adaptive immune cell function and responses to heterologous stimuli.
The non-specific effects of vaccines on the adaptive immune system differ between various vaccines. For example, the BCG vaccine has been shown to boost CD8+ T cell responses by promoting antigen release into the cytosol. Other vaccines that have not been associated with changes in all-cause mortality may still alter adaptive immune responses to unrelated stimuli.
Immunization Coalitions: Power of Collaboration
You may want to see also
Explore related products
Vaccines activate the adaptive immune system
The immune system is divided into two subsystems: the innate or general resistance system, and the adaptive system. The innate immune system provides a first line of defence against pathogenic agents, but its responses are not specific to a particular pathogen. On the other hand, the adaptive immune system is specific to a particular pathogen and has memory, meaning that it responds more rapidly to a particular pathogen with each successive exposure.
Vaccines contain weakened or inactive parts of a particular antigen, which triggers an immune response within the body. This immune response involves the production of "memory" B- and T-cells, which means that if the body is exposed to the same pathogen in the future, it can respond immediately and prevent serious illness. B-cells produce antibodies that fight off infection, while T-cells recognise and kill cells infected with a virus or other foreign cells, stopping the infection from spreading.
In addition to activating the adaptive immune system, vaccines can also have beneficial non-specific effects. For example, the bacille Calmette–Guérin (BCG) vaccine has been shown to induce innate immune memory, termed 'trained immunity', in monocytes and natural killer cells. This review discusses current evidence for vaccine-induced immunomodulation of adaptive immune cells and heterologous adaptive immune responses. Several studies have reported changes in the numbers or proportions of adaptive immune cell populations following vaccination, as well as effects on adaptive immune cell function and responses to heterologous stimuli.
Hep B Vaccine: When Did It Start Being Given at Birth?
You may want to see also
Explore related products
![Immune Support 8 in 1 Capsules - Zinc Supplement, Vitamin D3, Vitamin C and Elderberry - Immune Booster Ginger Root, and Turmeric - [2-Pack]](https://m.media-amazon.com/images/I/71wWqf0G7xL._AC_UL320_.jpg)
Vaccines trigger an adaptive immune response
Vaccines are an essential tool in the fight to improve public health and prevent infectious diseases. They work by teaching the immune system to create antibodies to combat specific pathogens. The human body's immune system is composed of two subsystems: the innate immune system and the adaptive immune system. The innate immune system acts as the first line of defence, providing a rapid but non-specific response to pathogenic agents. On the other hand, the adaptive immune system takes longer to respond, but it has memory, allowing it to recognise and respond more quickly to specific pathogens with each successive exposure.
The adaptive immune system also creates memory cells, which remain in the body even after the initial threat has been eliminated. These memory cells allow the immune system to respond faster and more effectively if exposed to the same pathogen in the future. This is why vaccines provide long-lasting protection against specific diseases. The memory cells are ready to quickly produce antibodies if the body encounters the same pathogen again, preventing serious illness.
In addition to their specific target pathogens, vaccines can also have beneficial non-specific effects on the adaptive immune system. For example, the bacille Calmette–Guérin (BCG) vaccine has been shown to induce innate immune memory, or 'trained immunity', in certain immune cells. This results in changes in the adaptive immune cell populations and responses, which has significant implications for vaccine design and scheduling.
Overall, vaccines trigger an adaptive immune response by introducing antigens that stimulate the production of B-cells, antibodies, and T-cells. This response also creates memory cells, providing long-term protection against specific pathogens. The activation of the adaptive immune system through vaccination is a key mechanism in improving public health and preventing the spread of infectious diseases.
The Common Cold: Why No Vaccine Yet?
You may want to see also
Explore related products
$7.99
Vaccines' impact on heterologous adaptive immunity
Vaccines are an essential tool in the fight against infectious diseases. They work by teaching the immune system to create antibodies to combat specific pathogens. The immune system can be divided into two subsystems: the innate immune system and the adaptive immune system. The adaptive immune system is responsible for developing specific responses to particular pathogens, and it has a memory function that allows it to respond more rapidly to subsequent exposures to the same pathogen. This memory function is the basis of vaccination.
Heterologous adaptive immunity refers to the ability of the immune system to protect against multiple pathogens, even if they are not exactly the same as the one targeted by a specific vaccine. This phenomenon was initially thought to be due to similarities in T-cell and B-cell epitopes among different pathogens. However, it is now understood that adaptive immune lymphocytes are highly cross-reactive, which broadens the scope of heterologous immunity.
Several vaccines have been associated with changes in all-cause infant mortality, including the BCG, diphtheria-tetanus-pertussis (DTP), and measles-containing vaccines (MCV). These vaccines alter T-cell and B-cell immunity, leading to changes in the numbers or proportions of adaptive immune cell populations. Additionally, these vaccines can impact adaptive immune cell function and responses to heterologous stimuli. The non-specific effects of vaccines on heterologous adaptive immunity may involve mechanisms such as bystander activation, cross-reactivity, and other undefined mechanisms.
The understanding of heterologous immunity has important implications for vaccine design and scheduling. For example, the COVID-19 pandemic highlighted the role of heterologous immunity in vaccine-induced protection. Studies have shown that diphtheria-tetanus-pertussis and SARS-CoV-2 vaccinations in Indonesian children improved their adaptive immune responses to COVID-19, demonstrating the potential benefits of heterologous immunity in pandemic response.
In conclusion, vaccines have a significant impact on heterologous adaptive immunity by altering adaptive immune cell populations and responses to unrelated stimuli. This knowledge is crucial for developing effective vaccination strategies and improving global health outcomes.
MMR Vaccination: Protecting Our Children's Health
You may want to see also
Frequently asked questions
The adaptive immune system is one of the two subsystems of the immune system, the other being the innate immune system. The adaptive immune system is specific to a particular pathogenic agent and takes longer to respond than the innate response. It has memory, which means that it responds more rapidly to a particular pathogen with each successive exposure.
Vaccines contain weakened or inactive parts of a particular organism (antigen) that triggers an immune response within the body. The body's first line of defence, the innate immune response, is triggered almost immediately. Vaccines also help produce "memory" B- and T-cells, which means that if you become ill in the future with the pathogen you’re vaccinating against, your immune system is trained to protect you and prevent serious illness.
Vaccines induce antigen-specific memory in adaptive immune cells that enable long-lived protection against the target pathogen. Vaccines also alter adaptive immune cell populations and heterologous immune responses.
Vaccines have helped eradicate smallpox, nearly end polio, and significantly reduce the number of cases of measles. Vaccines have also helped change the course of the global COVID-19 pandemic.
